What do analysts expect the price target to be for GERON CORP (GERN)?
13 analysts have analysed GERN and the average price target is 3.32 USD. This implies a price increase of 99.7% is expected in the next year compared to the current price of 1.66.
NASDAQ:GERN • US3741631036
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GERON CORP (GERN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-05 | Needham | Maintains | Buy -> Buy |
| 2025-07-10 | Goldman Sachs | Reiterate | Sell |
| 2025-05-08 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-03-12 | Needham | Reiterate | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-27 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Stifel | Maintains | Buy -> Buy |
| 2025-02-27 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-02-18 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-01-13 | Needham | Maintains | Buy -> Buy |
| 2024-12-13 | Needham | Reiterate | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | HC Wainwright & Co. | Initiate | Buy |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-09-09 | Leerink Partners | Initiate | Outperform |
| 2024-08-09 | Needham | Reiterate | Buy -> Buy |
| 2024-07-26 | Needham | Reiterate | Buy -> Buy |
| 2024-06-11 | Barclays | Initiate | Overweight |
| 2024-06-10 | Stifel | Maintains | Buy -> Buy |
| 2024-06-10 | Barclays | Initiate | Overweight |
| 2024-06-07 | Needham | Maintains | Buy -> Buy |
| 2024-06-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 237K -60.50% | 76.994M 32,386.92% | 183.881M 138.83% | 233.36M 26.91% | 335.46M 43.75% | 486.85M 45.13% | 701.06M 44.00% | 931.92M 32.93% | 647.5M -30.52% | 739.5M 14.21% | 819.37M 10.80% | |
| EBITDA YoY % growth | -193.502M -39.96% | -173.186M 10.50% | -51.079M 70.51% | -28.411M 44.38% | -45.603M -60.51% | -18.865M 58.63% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -193.944M -39.98% | -173.732M 10.42% | -51.553M 70.33% | -15.012M 70.88% | 20.876M 239.06% | 62.352M 198.68% | 333.85M 435.43% | 546.09M 63.57% | 413.1M -24.35% | 504.9M 22.22% | 566.1M 12.12% | |
| Operating Margin | -81,832.91% | -225.64% | -28.04% | -6.43% | 6.22% | 12.81% | 47.62% | 58.60% | 63.80% | 68.28% | 69.09% | |
| EPS YoY % growth | -0.33 8.33% | -0.27 18.18% | -0.10 62.96% | -0.04 55.80% | 0.03 157.70% | 0.04 40.00% | 0.35 871.43% | 0.59 70.59% | 0.12 -79.31% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 27.48% | -0.01 34.57% | -0.01 72.80% | -0.01 68.53% | 0.01 146.88% | 0.02 255.88% | 0.02 350.00% | 0.03 586.22% |
| Revenue Q2Q % growth | 51.104M 29.04% | 55.195M 12.56% | 60.224M 27.52% | 66.841M 39.21% | 73.015M 42.88% | 79.653M 44.31% | 86.29M 43.28% | 92.928M 39.03% |
| EBITDA Q2Q % growth | -6.658M 59.83% | -8.065M 33.87% | -6.504M 51.83% | -7.129M 11.27% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.825M 47.17% | -4.493M 63.92% | -1.109M 92.01% | -585.276K 93.12% | 10.355M 217.34% | 16.86M 475.23% | 20.304M 1,930.93% | 26.81M 4,680.74% |
All data in USD
13 analysts have analysed GERN and the average price target is 3.32 USD. This implies a price increase of 99.7% is expected in the next year compared to the current price of 1.66.
GERON CORP (GERN) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of GERON CORP (GERN) is -0.02 USD and the consensus revenue estimate is 51.10M USD.
The consensus rating for GERON CORP (GERN) is 78.4615 / 100 . This indicates that analysts generally have a positive outlook on the stock.